255 related articles for article (PubMed ID: 27587010)
1. Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications.
Kostić M; Djakovic L; Šujić R; Godman B; Janković SM
Appl Health Econ Health Policy; 2017 Feb; 15(1):85-93. PubMed ID: 27587010
[TBL] [Abstract][Full Text] [Related]
2. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
[TBL] [Abstract][Full Text] [Related]
3. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
4. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
[TBL] [Abstract][Full Text] [Related]
5. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study.
Yu Q; Zhu C; Feng S; Xu L; Hu S; Chen H; Chen H; Yao S; Wang X; Chen Y
J Med Internet Res; 2021 Jan; 23(1):e20629. PubMed ID: 33399540
[TBL] [Abstract][Full Text] [Related]
6. The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
Pillai N; Dusheiko M; Maillard MH; Rogler G; Brüngger B; Bähler C; Pittet VEH;
J Crohns Colitis; 2019 May; 13(6):744-754. PubMed ID: 30916775
[TBL] [Abstract][Full Text] [Related]
7. Self-reported Health Care Utilization of Patients with Inflammatory Bowel Disease Correlates Perfectly with Medical Records.
Severs M; Petersen RE; Siersema PD; Mangen MJ; Oldenburg B
Inflamm Bowel Dis; 2016 Mar; 22(3):688-93. PubMed ID: 26835981
[TBL] [Abstract][Full Text] [Related]
8. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
[TBL] [Abstract][Full Text] [Related]
9. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.
Kappelman MD; Rifas-Shiman SL; Porter CQ; Ollendorf DA; Sandler RS; Galanko JA; Finkelstein JA
Gastroenterology; 2008 Dec; 135(6):1907-13. PubMed ID: 18854185
[TBL] [Abstract][Full Text] [Related]
10. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.
Sin AT; Damman JL; Ziring DA; Gleghorn EE; Garcia-Careaga MG; Gugig RR; Hunter AK; Burgis JC; Bass DM; Park KT
Inflamm Bowel Dis; 2015 Jun; 21(6):1368-77. PubMed ID: 25839776
[TBL] [Abstract][Full Text] [Related]
11. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
12. [Cost measurement based on a cost diary in patients with inflammatory bowel disease].
Rösch M; Leidl R; Tirpitz Cv; Reinshagen M; Adler G; König HH
Z Gastroenterol; 2002 Apr; 40(4):217-28. PubMed ID: 11961730
[TBL] [Abstract][Full Text] [Related]
13. Direct health care insurer and out-of-pocket expenditures of inflammatory bowel disease: evidence from a US national survey.
Gunnarsson C; Chen J; Rizzo JA; Ladapo JA; Lofland JH
Dig Dis Sci; 2012 Dec; 57(12):3080-91. PubMed ID: 22790905
[TBL] [Abstract][Full Text] [Related]
14. Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease.
Severs M; Mangen MJ; van der Valk ME; Fidder HH; Dijkstra G; van der Have M; van Bodegraven AA; de Jong DJ; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; van de Meeberg PC; Mahmmod N; Ponsioen CY; Vermeijden JR; van der Meulen-de Jong AE; Pierik M; Siersema PD; Oldenburg B;
J Crohns Colitis; 2017 Mar; 11(3):342-352. PubMed ID: 27647859
[TBL] [Abstract][Full Text] [Related]
15. Health care costs associated with Australian tertiary inflammatory bowel disease care.
Jackson B; Con D; Ma R; Gorelik A; Liew D; De Cruz P
Scand J Gastroenterol; 2017 Aug; 52(8):851-856. PubMed ID: 28509590
[TBL] [Abstract][Full Text] [Related]
16. Costs of inflammatory bowel disease in Germany.
Stark R; König HH; Leidl R
Pharmacoeconomics; 2006; 24(8):797-814. PubMed ID: 16898849
[TBL] [Abstract][Full Text] [Related]
17. Health Care Cost for Children Newly Diagnosed With Inflammatory Bowel Disease.
Fondell AW; Mosha MH; Frank CR; Brangi JM; Hyams JS
Inflamm Bowel Dis; 2020 Mar; 26(4):635-640. PubMed ID: 31504513
[TBL] [Abstract][Full Text] [Related]
18. The cost of illness analysis of inflammatory bowel disease.
Pakdin M; Zarei L; Bagheri Lankarani K; Ghahramani S
BMC Gastroenterol; 2023 Jan; 23(1):21. PubMed ID: 36658489
[TBL] [Abstract][Full Text] [Related]
19. Societal costs attributable to Crohn's disease and ulcerative colitis within the first 5 years after diagnosis: a Danish nationwide cost-of-illness study 2002-2016.
Vadstrup K; Alulis S; Borsi A; Elkjaer Stallknecht S; Nielsen A; Rikke Jørgensen T; Wennerström C; Qvist N; Munkholm P
Scand J Gastroenterol; 2020 Jan; 55(1):41-46. PubMed ID: 31960726
[No Abstract] [Full Text] [Related]
20. Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany.
Wilke T; Groth A; Long GH; Tatro AR; Sun D
Clin Ther; 2020 Jan; 42(1):130-143.e3. PubMed ID: 31883702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]